You are here

Heart Failure

 

While 71 percent of heart patients are prescribed statins after hospitalization for heart disease, cerebrovascular disease and peripheral artery disease, just 37.4 percent retain that medication regimen a year later, researchers in Salt Lake City reported this week.

Patients who suffer brain damage after cardiac arrest could benefit from magnetic resonance (MR) imaging following their stabilization—a measure that has been shown to predict clinical outcomes through mapping brain activity, according to new research published in the American journal Radiology.

Ventricular assist devices (VADs) foster improved survival for children awaiting heart transplantation when compared to the current standard of extracorporeal membrane oxygenation (ECMO), according to a new study in the Journal of the American College of Cardiology.

African Americans are dying an average of 3.4 years before white Americans, a significant gap that’s attributable to more prevalent cardiovascular disease (CVD) and risk factors in the black population, the American Heart Association (AHA) reported in a scientific statement published Monday in Circulation.

Cardiovascular research has traditionally focused on hard clinical endpoints such as markers of disease progression, adverse events and death. But now researchers are calling for more studies that incorporate the viewpoints of patients and caregivers, both in trial design and execution and in measuring outcomes like quality of life, time off work, out-of-pocket expense and caregiver burden.

 

Recent Headlines

New heart failure treatment increases ejection fraction by 38% in 1st clinical patient

The first clinical patient to undergo a new, less invasive treatment for heart failure has been discharged from University Hospital Zurich in Switzerland and is recovering well, according to a press release from BioVentrix.

Sudden cardiac death a significant contributor to mortality in women, regardless of CAD status

Sudden cardiac death is a significant contributor to mortality in women, regardless of presence of coronary artery disease (CAD), according to a six-year study published in the Journal of the American Heart Association.

Researchers link aldosterone, plasma renin activity to increased risk for CVD in black Americans

Increased levels of aldosterone and plasma renin activity (PRA) are associated with greater risk of cardiovascular disease (CVD) and all-cause mortality among blacks in the U.S., according to a community-based study.

Hearts with improving LVSD can be safely transplanted

Donor hearts with left ventricular systolic dysfunction (LVSD) can be revived and transplanted as successfully as other hearts, according to a study in the Journal of the American College of Cardiology.

6 data points about rheumatic heart disease as global rates decline

Over the past quarter-century, the worldwide burden of rheumatic heart disease has declined although high rates of the illness persist in certain poor regions, including Oceania, South Asia and sub-Saharan Africa, a new study finds.

Prostate cancer treatment associated with higher risk of heart failure

Men with early-stage prostate cancer who receive androgen deprivation therapy are at significantly higher risk for heart failure, according to a study published in the British Journal of Cancer.

Take a seat: 12-year study ties prolonged standing to CVD risks

Plenty plenty of research has shown sitting down at work can present health problems. But a recent study from a team in Canada examined how prolonged standing at work can impact one’s risk for cardiovascular disease (CVD)—and the results were surprising. Those who stand are at a much greater risk for CVD.

Research funds for cardiac arrest—down 63% since 2010—disproportionately low compared to heart disease, stroke

Funding for cardiac arrest (CA) research lags far behind other leading causes of death in the United States, according to research published in the Journal of the American Heart Association.

New trial to test transcatheter ventricular enhancement procedure

A new clinical trial is underway to test a closed-chest procedure designed to treat patients with ischemic cardiomyopathy.

Maximally tolerated dose can reduce mitral regurgitation

Medication was effective in treating nearly 40 percent of heart failure patients experiencing functional mitral regurgitation (FMR) with reduced ejection fraction (HFrEF), according to a new study in JACC: Heart Failure.

Pages